<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Vani K</submitter><funding>NCATS NIH HHS</funding><funding>NCI NIH HHS</funding><pagination>463-477</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5533270</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>65(8)</volume><pubmed_abstract>Clinical Immunohistochemistry (IHC) laboratories face unique challenges in performing accurate and reproducible immunostains. Among these challenges is the use of homemade controls derived from pathological discard samples. Such positive controls have an unknown number of analyte molecules per cell (epitope density). It is unclear how the lack of defined analyte concentrations affects performance of the control. To address this question, we prepared positive IHC controls ( IHControls) for human epidermal growth factor receptor type II (HER-2), estrogen receptor (ER), or progesterone receptor (PR) with well-defined, homogeneous, and reproducible analyte concentrations. Using the IHControls, we examined the effect of analyte concentration on IHC control sensitivity. IHControls and convention</pubmed_abstract><journal>The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society</journal><pubmed_title>The Importance of Epitope Density in Selecting a Sensitive Positive IHC Control.</pubmed_title><pmcid>PMC5533270</pmcid><funding_grant_id>UL1 TR001064</funding_grant_id><funding_grant_id>R44 CA183203</funding_grant_id><funding_grant_id>R44 CA213476</funding_grant_id><pubmed_authors>Balasubramanian A</pubmed_authors><pubmed_authors>Goldsmith JD</pubmed_authors><pubmed_authors>Pilichowska M</pubmed_authors><pubmed_authors>Sompuram SR</pubmed_authors><pubmed_authors>Vani K</pubmed_authors><pubmed_authors>Noubary F</pubmed_authors><pubmed_authors>Chang KG</pubmed_authors><pubmed_authors>Bogen SA</pubmed_authors><pubmed_authors>Schaedle AK</pubmed_authors><pubmed_authors>Naber S</pubmed_authors></additional><is_claimable>false</is_claimable><name>The Importance of Epitope Density in Selecting a Sensitive Positive IHC Control.</name><description>Clinical Immunohistochemistry (IHC) laboratories face unique challenges in performing accurate and reproducible immunostains. Among these challenges is the use of homemade controls derived from pathological discard samples. Such positive controls have an unknown number of analyte molecules per cell (epitope density). It is unclear how the lack of defined analyte concentrations affects performance of the control. To address this question, we prepared positive IHC controls ( IHControls) for human epidermal growth factor receptor type II (HER-2), estrogen receptor (ER), or progesterone receptor (PR) with well-defined, homogeneous, and reproducible analyte concentrations. Using the IHControls, we examined the effect of analyte concentration on IHC control sensitivity. IHControls and convention</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Aug</publication><modification>2025-04-26T08:59:00.175Z</modification><creation>2019-03-26T23:48:34Z</creation></dates><accession>S-EPMC5533270</accession><cross_references><pubmed>28665229</pubmed><doi>10.1369/0022155417714208</doi></cross_references></HashMap>